Hyasynth

Despite its increasing popularity in medicine, Cannabis is too costly to produce at large scale with the quality and consistency needed for medical use. Instead of depending on the cannabis plant and breeding new strains, we use engineered yeast to produce the same products, including THC, CBD and even many of the minor cannabinoids, which are only found in small quantities in the plant. Compared to plants, our process is expontentially cheaper, faster and reaches the quality that patients, doctors and researchers can depend on.

REQUEST INTRODUCTION USING

LINKEDIN ANGELLIST

COMPANY PEOPLE

Zach Wiltshire

Zach Wiltshire
COO, Co-founder at Hyasynth Bio

Kevin Chen

Kevin Chen
CEO, Co-founder

Shoham Mookerjee

Shoham Mookerjee
CTO at Hyasynth Bio and Graduate Student at Concordia University

Alex Campbell

Alex Campbell
Co-founder at Hyasynth

YOU MIGHT ALSO BE INTERESTED IN

SERIES-A

Synthace Limited

Powering the Engineering of Biology

LONDON, UNITED KINGDOM

SEED

Kilobaser

The Nespresso machine for DNA synthesis

GRAZ, AUSTRIA

SEED

Verdex

Non-toxic nanofibers for filters

WEST PALM BEACH, FL